Range
29.65 - 31.09
Vol / Avg.
70.9K/150.5K
Div / Yield
-
52 Wk
23.69 - 63.41
Mkt Cap
1.1B
Payout Ratio
-
Open
29.65
P/E
-
EPS
-0.75
Shares
34.9M
Outstanding
34.9M
Total Float
17.5M
Benzinga - May 27, 2021, 8:48AM
Benzinga - May 17, 2021, 6:20AM
Benzinga - May 13, 2021, 4:21PM
Benzinga - Apr 6, 2021, 7:46AM
Benzinga - Mar 30, 2021, 7:20AM
Benzinga - Mar 29, 2021, 4:19PM
Benzinga - Jan 4, 2021, 4:45PM
Benzinga - Dec 29, 2020, 5:56PM
Benzinga - Dec 29, 2020, 7:20AM
Benzinga - Dec 29, 2020, 6:54AM
Benzinga - Dec 29, 2020, 6:10AM
Benzinga - Dec 14, 2020, 6:31AM
load more
Sector: Health Care.Industry: Biotechnology
Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.390-0.540 -0.1500
REV0
Q4 2020Est.ActualSurprise
EPS-1.370
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SBTXSilverback Therapeutics0%1.1B

Silverback Therapeutics Frequently Asked Questions

Q

How do I buy Silverback Therapeutics (SBTX) stock?

A

You can purchase shares of Silverback Therapeutics (NASDAQ: SBTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Silverback Therapeutics's (SBTX) competitors?

A

Other companies in Silverback Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Humanigen (NASDAQ:HGEN), Mesoblast (NASDAQ:MESO) and Vaxcyte (NASDAQ:PCVX).

Q

What is the target price for Silverback Therapeutics (SBTX) stock?

A

The latest price target for Silverback Therapeutics (NASDAQ: SBTX) was reported by JonesTrading on May 27, 2021. The analyst firm set a price target for 50.00 expecting SBTX to rise to within 12 months (a possible 61.24% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Silverback Therapeutics (SBTX)?

A

The stock price for Silverback Therapeutics (NASDAQ: SBTX) is $31.01 last updated Today at 8:00:04 PM.

Q

Does Silverback Therapeutics (SBTX) pay a dividend?

A

There are no upcoming dividends for Silverback Therapeutics.

Q

When is Silverback Therapeutics (NASDAQ:SBTX) reporting earnings?

A
Silverback Therapeutics’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Silverback Therapeutics (SBTX) going to split?

A

There is no upcoming split for Silverback Therapeutics.

Q

What sector and industry does Silverback Therapeutics (SBTX) operate in?

A

Silverback Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.